The Insulin Lispro Injection, cataloged under National Stock Number 6505-01-440-7640, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Eli Lilly and Company. Government technical data includes 3 specifications, cited from the U.S. Government catalog. The record lists 5 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-440-7640 |
| Primary Part Number | NDC00002-7510-01 |
| Item Name | Insulin Lispro Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Eli Lilly and Company |
| Status | ACTIVE |
| Primary Container Content Quantity | 10.0 MILLILITERS |
| Supplementary Features | INSULIN LISPRO, RECOMBINANT; (RDNA) 100 UNITS PER ML; 10 ML; VIAL |
| Primary Container Type | VIAL |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| HUM68W | Aah Pharmaceuticals Ltd (GBR) |
| NDC00002-7510-01 PRIMARY | Eli Lilly and Company (USA) |
| 5014602100957 | Lilly Eli & Co Ltd (GBR) |
| 2310498 | Unichem Limited (GBR) |
| 231-0498 | Lilly Eli & Co Ltd (GBR) |
| Reference | Meaning |
|---|---|
| HUMALOG | 5/1 Secondary reference Eli Lilly and Company |
| 96-0758 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-440-7640 is a Insulin Lispro Injection, manufactured by Eli Lilly and Company, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-440-7640 has 5 manufacturer part numbers on file: HUM68W (Aah Pharmaceuticals Ltd), NDC00002-7510-01 (Eli Lilly and Company), 5014602100957 (Lilly Eli & Co Ltd), 2310498 (Unichem Limited), 231-0498 (Lilly Eli & Co Ltd).
Key specifications for NDC00002-7510-01: Primary Container Content Quantity: 10.0 MILLILITERS; Supplementary Features: INSULIN LISPRO, RECOMBINANT; (RDNA) 100 UNITS PER ML; 10 ML; VIAL; Primary Container Type: VIAL; Part Name Assigned by Controlling Agency: INSULIN LISPRO INJECTION 100 UNITS PER ML 10ML VIAL. 3 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.